BILIARY TRACT CANCERS
Clinical trials for BILIARY TRACT CANCERS explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT CANCERS trials appear
Sign up with your email to follow new studies for BILIARY TRACT CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple threat: drug cocktail and precision radiation take on tough bile duct cancer
Disease control OngoingThis phase II trial tests a combination of two drugs (anlotinib and cadonilimab) plus a special type of radiation (PULSAR) in 26 people with advanced bile duct cancer that has worsened after standard treatment. The goal is to see if this triple therapy can shrink tumors and contr…
Matched conditions: BILIARY TRACT CANCERS
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New cancer drug ABBV-400 enters early human testing
Disease control OngoingThis early-phase trial tests an investigational drug called ABBV-400 in about 300 adults with advanced solid tumors, including liver, pancreatic, breast, and ovarian cancers. The study aims to see if the drug can shrink tumors and to check for side effects. Participants receive A…
Matched conditions: BILIARY TRACT CANCERS
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC